Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma
暂无分享,去创建一个
T Kawaguchi | D. Ichikawa | E. Otsuji | N. Yagi | A. Shiozaki | H. Fujiwara | S. Komatsu | K. Okamoto | H. Konishi | S Komatsu | D Ichikawa | H Konishi | A Shiozaki | K Okamoto | E Otsuji | T Arita | H Fujiwara | S Hirajima | M Miyamae | W Okajima | T Ohashi | N Yagi | T. Ohashi | T. Arita | T. Kawaguchi | M. Miyamae | S. Hirajima | W. Okajima | N. Yagi | Mahito Miyamae | Takuma Ohashi | Wataru Okajima
[1] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[2] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[3] D. Ichikawa,et al. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma , 2013, British Journal of Cancer.
[4] H. Matsubara,et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma , 2013, British Journal of Cancer.
[5] E. Kroh,et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.
[6] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[7] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[8] P. Hainaut,et al. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. , 1998, Cancer research.
[9] D. Ichikawa,et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer , 2011, British Journal of Cancer.
[10] G. Tseng,et al. MCM7 amplification and overexpression are associated with prostate cancer progression , 2006, Oncogene.
[11] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[12] E. Li,et al. Down‐regulated desmocollin‐2 promotes cell aggressiveness through redistributing adherens junctions and activating beta‐catenin signalling in oesophageal squamous cell carcinoma , 2013, The Journal of pathology.
[13] Fang Wang,et al. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. , 2006, Biochemical and biophysical research communications.
[14] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[15] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[16] Fang Zhou,et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.
[17] Yibo Gao,et al. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. , 2012, Biochemical and biophysical research communications.
[18] T Kawaguchi,et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma , 2012, British Journal of Cancer.
[19] Xi Chen,et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. , 2010, Clinical chemistry.
[20] Xin Lu,et al. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. , 2011, Oncology reports.
[21] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[22] Yang Li,et al. Role of the miR‐106b‐25 microRNA cluster in hepatocellular carcinoma , 2009, Cancer science.
[23] G. Tsujimoto,et al. Ultrasensitive DNA chip: gene expression profile analysis without RNA amplification. , 2006, Journal of biochemistry.
[24] Justin L. Mott,et al. miR‐25 targets TNF‐related apoptosis inducing ligand (TRAIL) death receptor‐4 and promotes apoptosis resistance in cholangiocarcinoma , 2012, Hepatology.
[25] E. Kroh,et al. Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels , 2013, PloS one.
[26] A. Akobeng,et al. Understanding diagnostic tests 3: receiver operating characteristic curves , 2007, Acta paediatrica.
[27] T. Visakorpi,et al. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer , 2012, Oncogene.
[28] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[29] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[30] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[31] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[32] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[33] Shengtao Zhu,et al. Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma. , 2011, Cancer letters.
[34] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[35] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[36] Zuhong Lu,et al. Analysis of serum genome-wide microRNAs for breast cancer detection. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[37] Yong Li,et al. Negative Regulation of the Tumor Suppressor p53 Gene by MicroRNAs , 2010, Oncogene.
[38] Y. Kajiyama,et al. Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[39] C. Croce,et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis , 2008, Proceedings of the National Academy of Sciences.
[40] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[41] U. Reinhold,et al. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. , 2001, Clinical chemistry.
[42] Y. Matsuki,et al. Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.
[43] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[44] Xi Chen,et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] J. Nikliński,et al. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[46] R Montesano,et al. Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[48] D. Ichikawa,et al. Circulating microRNA in digestive tract cancers. , 2012, Gastroenterology.
[49] D. Ichikawa,et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma , 2012, Expert opinion on biological therapy.
[50] F. Sato,et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. , 2009, Gastroenterology.
[51] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[52] K. Hatakeyama,et al. Clinical Significance of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, and Squamous Cell Carcinoma Antigen Levels in Esophageal Cancer Patients , 2004, World Journal of Surgery.
[53] D. Ichikawa,et al. Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer , 2013, British Journal of Cancer.
[54] Kenichi Sugihara,et al. Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.
[55] Masayuki Watanabe,et al. Serum microRNA‐21 is a novel biomarker in patients with esophageal squamous cell carcinoma , 2012, Journal of surgical oncology.
[56] Michael J Kerin,et al. Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer , 2010, Annals of surgery.
[57] D. Iliopoulos,et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.
[58] Wei Shi,et al. Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.
[59] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[60] D. Birnbaum,et al. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. , 1995, British Journal of Cancer.
[61] M. Loda,et al. Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.
[62] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[63] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[64] J. Inazawa,et al. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DP1 gene in the 13q34 amplicon , 1999, Genes, chromosomes & cancer.
[65] N. Hu,et al. MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells. , 2011, American journal of cancer research.
[66] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[67] S. Zhang,et al. Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma. , 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[68] Ugo Boggi,et al. High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer , 2012, PloS one.
[69] Ann M. Killary,et al. MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.
[70] Fedor V. Karginov,et al. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. , 2009, Genes & development.
[71] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.
[72] K. Chayama,et al. Genetic polymorphisms and esophageal cancer risk , 2007, International journal of cancer.
[73] G. Fan,et al. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. , 2011, American journal of cardiovascular disease.